Acorda Therapeutics (ACOR)
Your Dashboard
Displaying ACOR Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 20.01M
- Accounts Receivable 21.53M
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization 0.8369
- Beneish M-Score Pro
- Beta Pro
- Book Value 219.09M
- Book Value per Share 5.519
- Capital Expenditures 3.104M
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing 1.74M
- Cash Financing TTM 3.583M
- Cash Investing -7.406M
- Cash Investing TTM -108.21M
- Cash Operations 3.012M
- Cash Operations TTM 81.47M
- Cash and Equivalents 55.30M
- Cash and ST Investments 278.55M
- Current Ratio 4.238
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.0241
- Dividend
- Dividend Yield 0.00%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share 0.19
- Earnings Per Share Growth
- Earnings Per Share TTM 0.97
- Earnings Yield 4.30%
- Effective Tax Rate TTM Pro
- Enterprise Value 844.81M
- Expenses 63.40M
- Expenses TTM 263.08M
- Free Cash Flow -0.092M
- Free Cash Flow TTM 76.92M
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin 82.28%
- Gross Profit TTM 235.22M
- Income from Cont. Ops Pro
- Interest Expense 0.766M
- Interest Income 0.129M
- Inventories 28.66M
- KZ Index Pro
- Liabilities 166.96M
- Long Term Debt 4.126M
- Market Cap 894.84M
- Net Income 7.846M
- Net Income TTM 39.12M
- Net PP&E 6.521M
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio 23.24
- PE Value Pro
- PEG Ratio 0.0722
- PS Value Pro
- Payout Ratio TTM Pro
- Price 22.54
- Price / Book Value 4.084
- Price / Sales Ratio 2.961
- Price / Tangible Book Value Pro
- Profit Margin 11.01%
- R&D Expense 11.02M
- Receivables Turnover 13.47
- Retained Earnings -401.64M
- Retained Earnings Growth
- Return on Assets 10.93%
- Return on Equity 21.06%
- Return on Invested Capital Pro
- Revenue Growth 16.25%
- Revenue Per Share TTM 7.612
- Revenues 71.25M
- Revenues TTM 302.20M
- SG&A Expense 38.74M
- Shareholders Equity 219.09M
- Shares Outstanding 39.70M
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 386.05M
- Total Return Price 22.54
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these ACOR related companies
ACOR News
Pre-Open Movers 5/18: (PSUN) (WGO) (CRM) Higher; (ADSK) (SQNM) (ARUN) Lower (more...)
May 18, 9:28AM Street Insider
May 18, 9:28AM Street Insider
News related to $ACOR, currently -1.1% since open: 'Alkermes takes bigger 4Q loss after Elan deal' http://stks.co/3sPL
about 10 days ago by TradeBot
about 10 days ago by TradeBot
2012 Economic Outlook - Report Highlights Acorda Therapeutics Inc and Pharmacyclics, Inc.
May 17, 9:00AM Marketwire
May 17, 9:00AM Marketwire
Listen to $ACOR Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3e2R
about 24 days ago by earningscast
about 24 days ago by earningscast
Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Second Consecutive Year
Apr 30, 7:00AM Business Wire
Apr 30, 7:00AM Business Wire
Acorda Therapeutics to Host Conference Call to Discuss First Quarter 2012 Financial Results on May 3, 2012
Apr 26, 6:00AM Business Wire
Apr 26, 6:00AM Business Wire
Listen to $ACOR Acorda Therapeutics, Inc. Research & Development Conf Call - live at 10:00 AM, ondemand after - http://stks.co/3NSr
about 40 days ago by earningscast
about 40 days ago by earningscast
Acorda Therapeutics Named One of the 100 Most Trustworthy Companies by Forbes
Apr 12, 7:00AM Business Wire
Apr 12, 7:00AM Business Wire
$ACOR my biotech stock is back!!!! What happened here up another buck!
about 72 days ago by HTB_Krull
about 72 days ago by HTB_Krull
Acorda Therapeutics to Present at the Cowen & Company 32nd Annual Health Care Conference
Feb 27, 7:30AM Business Wire
Feb 27, 7:30AM Business Wire
Acorda Therapeutics to Present at 2012 RBC Capital Markets' Global Healthcare Conference
Feb 22, 6:00AM Business Wire
Feb 22, 6:00AM Business Wire
Acorda Therapeutics to Present at Citi 2012 Global Health Care Conference
Feb 21, 6:00AM Business Wire
Feb 21, 6:00AM Business Wire
Citi Downgrades Acorda Therapeutics, Inc. (ACOR) to Neutral, Raises Price Target to $29
Feb 17, 7:36AM Street Insider
Feb 17, 7:36AM Street Insider
Big earnings beat for $acor, but the market is not too excited yet. It has 6 days of short interest, so it is one to watch if it gets going
about 101 days ago by ivanhoff
about 101 days ago by ivanhoff
Listen to $ACOR Q4 2011 earnings call (EPS 0.45 vs est 0.18) - live at 08:30 AM, ondemand after - http://stks.co/2RDb
about 101 days ago by earningscast
about 101 days ago by earningscast
Listen to $ACOR Acorda Therapeutics, Inc. at Biotechnology Industry Organization - live at 01:00 PM, ondemand after - http://stks.co/2Opp
about 103 days ago by earningscast
about 103 days ago by earningscast
$ACOR may be flashing pocket pivot today as it rebounds from its 50-day line in above average volume. Strong fundamentals. Good accumulation
about 104 days ago by JeanPaul
about 104 days ago by JeanPaul
BIO CEO Conference Live Blog. http://stks.co/2N3g $ONTY $KERX $GILD $CYCC $IDIX $CHTP $ACOR
about 104 days ago by abubnic
about 104 days ago by abubnic
$REGN is one just started shorting since hitting near $102 mon, little scalps have netted a few pts , has ER next wk with $ACOR & $NPSP
about 109 days ago by ronin245
about 109 days ago by ronin245
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ACOR | 22.54 | -0.12 | -0.53% | 894.84M |
| ACOM | 21.88 | +0.09 | +0.41% | 937.78M |
| ACO | 29.03 | -0.83 | -2.78% | 924.90M |
| ACN | 57.44 | -0.55 | -0.95% | 37.18B |
| ACM | 16.69 | +0.06 | +0.36% | 1.955B |
| ACLS | 1.12 | +0.11 | +10.89% | 120.00M |
| ACIW | 40.03 | -0.07 | -0.17% | 1.568B |
| ACI | 7.23 | -0.07 | -0.96% | 1.533B |
| ACHN | 7.35 | +0.03 | +0.41% | 518.69M |
| ABB | 16.18 | -0.22 | -1.34% | 37.45B |
